Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tumor
Pharma
Moffitt Dyves back into tumor pH modulation
After seeing patients repeatedly reject oral therapy, researchers at Moffitt have teamed up with Dyve to collaborate on a transdermal pH modulator.
Nick Paul Taylor
Feb 7, 2022 7:40am
Improving immunotherapy delivery by ordering tumor blood vessels
Nov 9, 2021 10:00am
AmMax, targeting a Daiichi market, posts data on rare tumor drug
Oct 26, 2021 8:35am
Biotech Sparx to build 1.2 million square foot plant in China
Jul 8, 2021 9:58am
Swiss scientists take sonic approach to targeted drug delivery
Oct 19, 2020 5:29pm
AstraZeneca's Tagrisso cuts lung cancer recurrence by 83%
May 28, 2020 5:00pm
